₹ 28.77
-0.83 (-2.80%)
BSE
G
Goldline Pharmaceutical
₹ 28.77
BSE
GLPL Financials Summary
Goldline Pharmaceutical revenue increased 30.67% quarter-on-quarter to ₹10 Cr in Mar 2026, while net profit increased 111.11% quarter-on-quarter to ₹2 Cr. EPS for the quarter stood at ₹2.18, increased from ₹1.00 in the previous quarter.
Goldline Pharmaceutical Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of GLPL Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
GLPL Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

